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Worldwide an estimated 200 million women and girls have been subjected to female genital 
mutilation (FGM/C), a traditional practice involving partial or total removal of external genitalia for 
non-medical reasons. Previous research suggests that FGM/C may be associated with increased 
risk of acquiring human immunodeficiency virus (HIV). However, there is limited research on the 
association between HIV and FGM/C. Studies investigating the association between male 
circumcision and HIV have demonstrated the protective effect of male circumcision. Given that, in 
some settings, FGM/C and male circumcision are considered “equivalent” procedures, it is 
important to investigate the effect of FGM/C on the likelihood of HIV infection for women in 
practising communities. 
Methods 
This study examined the relationship between HIV prevalence, FGM/C status and key background 
characteristics such as age, education, household wealth, marital status, parity and residence 
among women aged 15 to 49 years. We analysed cross-sectional data from the Demographic and 
Health Surveys (DHS) implemented in the four sub-Saharan Africa countries for which data on HIV 
and FGM/C were available: Ethiopia (2005), The Gambia (2013), Kenya (2003 and 2008-09), and 
Sierra Leone (2008 and 2013). Datasets were analysed separately for each country. Using 
datasets where a statistically significant association was observed between HIV prevalence and 
FGM/C status, we adjusted for potential confounders and applied multilevel logistic models to 
explore the correlates of HIV infection and their association with FGM/C.  
Results 
The rate of FGM/C was high (>70%) in all countries except Kenya (28.7% in 2008-9 and 33.1% in 
2003). FGM/C types I (partial or complete removal of the clitoris and/or the clitoral hood) and II 
(partial or complete removal of the clitoris and labia minora; and, in some cases, the labia majora) 
were predominant in all countries except Ethiopia. In Ethiopia type III (removal of the labia minora 
and/or labia majora, followed by forcing the wound edges together to create a seal, for example 
through stitching) was common. HIV prevalence ranged from 1.7 percent (Ethiopia 2005) to 8.7 
percent (Kenya 2003). There was no statistically significant association between FGM/C status 
and HIV prevalence among women in Ethiopia, The Gambia and Sierra Leone.  In contrast, in the 
Kenya 2003 and 2008-2009 samples, cut women were less likely than uncut women to be HIV+, 
and this difference was statistically significant both in the bivariate analysis (OR 0.65, p<0.022 in 
2008-09; OR 0.56, p<0.001 in 2003) and after adjustment for potential confounders (AOR 0.49, 
p=0.002 in 2008-09; AOR 0.60, p=0.01 in 2008-09).   
Conclusions 
Findings are inconclusive. The reason for the inconsistent findings across the countries studied is 
unclear, but may be related to study limitations such as the cross-sectional design (which limits 
causal inferences), the possibility of other pathways of association (not included in the analyses) 
and the considerable geographical variation in HIV prevalence (which makes it difficult to assess 
its association with FGM/C particularly in low HIV-prevalence settings). Considering that FGM/C 
causes trauma to the genitalia, which can increase susceptibility to sexually transmitted infections, 





Female genital mutilation/cutting (FGM/C) is the partial or total removal of the external female 
genitalia for non-medical reasons. About 200 million women and girls across a range of African, 
Middle Eastern and Asian countries have experienced FGM/C (UNFPA-UNICEF, 2016), with 
millions more at risk of being cut during their lifetimes.  
Apart from its known association with complications such as obstructed labour and urinary fistulas 
(Mwanri and Gatwiri, 2017), psychological distress (Adelufosi et al., 2017), and sexual dysfunction 
(Abdel-Azim, 2013, Biglu et al., 2016), FGM/C has been postulated to increase the risk of HIV 
infection (e.g. Brady, 1999). However, HIV as an additional consequence of FGM/C has not been 
extensively studied.  
The Joint United Nations Programme on HIV/AIDS (UNAIDS) estimates that approximately 37 
million people were living with HIV worldwide as of 2016 and that almost the same number had 
died of HIV-related complications over the previous 25 years (UNAIDS, 2016). Two-thirds of all 
new HIV infections occur in sub-Saharan Africa, where women (and girls) are at higher risk of 
infection than men (and boys). This gender difference can be attributed to socio-cultural and 
gender norms that tend to disempower women in sexual relationships and may affect women’s 
ability to negotiate safer sex with male partners (see e.g. Ramjee and Daniels, 2013). The gender 
disparity may also reflect biological factors, as susceptibility to HIV infection may be higher for 
women than for men (Mastro and de Vincenzi, 1996, Royce, Sena, Cates et al., 1997). 
The prevalence of HIV shows regional variation throughout sub-Saharan Africa. Rates of HIV 
infection are highest in some parts of Southern Africa, where, incidentally, FGM/C is rarely 
practised, as well as in some parts of Western Africa, where the milder forms of FGM/C (types I1 
and II2) predominate. In African regions where the most severe form of FGM/C (type III3) is 
common, HIV prevalence tends to be low.  
Existing Literature 
At the population level, FGM/C appears to have a negative association with HIV. However, at the 
individual level, some experts have suggested that FGM/C may increase HIV risk among women 
(Brady, 1999). A recent literature review (Noah-Pinheiro, 2017) identified 14 quantitative studies 
conducted in several African countries with relevant data for an investigation of FGM/C and HIV at 
the individual level. The studies from both peer-reviewed (n=11) and grey literature (n=3), were 
selected based on the following predetermined criteria, even if they did not explicitly set out to 
explore a link between FGM/C and HIV: (1) FGM/C was an independent variable, and (2) HIV 
status was confirmed by a laboratory test.    
Though observational in design, the selected studies were acceptable because the review’s aim 
was to investigate an association between FGM/C and HIV, not to establish a causal relationship. 
The review assessed the measurement of FGM/C status (exposure) and HIV infection (outcome); 
control for potential confounders; sample source; sample size/power considerations (including 
prevalence of FGM/C and HIV); and response rate. The 14 studies were then rated based on 
criteria outlined in a Department for International Development (DFID) guidance document4: 
conceptual framing, openness and transparency, cogency, appropriateness and rigour, validity, 
 
1  Partial or complete removal of the clitoris and/or the clitoral hood 
2  Partial or complete removal of the clitoris and labia minora, and may include removal of the labia majora 
3  Removal of labia minora and/or labia majora, forcing the wound edges together to create a seal, by stitching, for example 





reliability and cultural sensitivity. Additional rating criteria included effect size and journal impact 
factor. 
Findings from the rating exercise were as follows: 
• Three of the 14 studies were determined to be low quality, 10 were of moderate quality, 
and one was of high quality.  
• Important limitations in study design affecting most studies included: 
o Poor statistical power 
o Limited adjustment for potential confounders 
o Measurement of FGM/C status by self-reporting   
• Four studies failed to find a statistically significant association between FGM/C and HIV, 
six found a negative association, two found a positive association and two reported indirect 
associations. 
• In general, studies that examined data from non-representative samples of women (such 
as antenatal clinic clients or hospitality workers) were equivocal. Those using data from 
nationally-representative samples of women mostly found a negative association, except 
for the two studies set in Kenya, which elicited indirect associations (positive and negative). 
No generalities could be made about data sources where a positive association was found.  
• The review concluded, with limited confidence, that FGM/C has the anticipated positive 
association with HIV, and called for further research. 
Aim 
This study adds to existing literature by examining the relationship between HIV prevalence, self-
reported FGM/C status and key background and sexual behaviour-related characteristics of 
women aged 15 to 49 years in four countries: Ethiopia, The Gambia, Kenya and Sierra Leone.  
Methods 
Design 
We analysed cross-sectional data from Demographic and Health Surveys (DHS) implemented in 
the four countries where data on HIV and FGM/C status was available. These countries included: 
Ethiopia (2005), The Gambia (2013), Kenya (2003, 2008-2009) and Sierra Leone (2008, 2013). 
Demographic and Health Surveys are nationally-representative household surveys that provide 
population, health and nutrition data for monitoring and impact evaluations.  
Data 
Analytical datasets comprised data from women with both FGM/C and HIV status data. Samples 
comprised 6,110 women from Ethiopia, 4,369 from The Gambia, 3,413 from Sierra Leone in 2008 
and 7,853 in 2013, and 3,339 women from Kenya in 2003 and 3,699 in 2008-2009. Although the 
DHS was implemented in Ethiopia in 2016 and Kenya in 2014, these rounds were excluded as 
they did not include HIV testing. Further details on the sampling and data collection procedures 
are available in the published country DHS reports (Central Bureau of Statistics [Kenya], Ministry 
of Health [Kenya], & ORC Macro, 2004; Central Statistical Agency [Ethiopia] & ORC Macro, 2006; 
Kenya National Bureau of Statistics & ICF Macro, 2010; Statistics Sierra Leone (SSL) & ICF Macro. 
2009; SSL & ICF International, 2014; The Gambia Bureau of Statistics & ICF International, 2014). 
The datasets analysed during the current study are publicly available in the USAID MEASURE/ 




FGM/C status was the primary independent variable. Respondents were asked, "Have you ever 
been circumcised?" Response options were “yes”, “no”, or “don’t know”. Only women who 
responded “yes” were classified as being cut.  
We included sociodemographic variables that have been found to be associated with FGM/C 
and/or HIV for descriptive purposes and for use as controls in multivariate analyses: age (Igwegbe 
& Egbuonu, 2000; Johnson & Way, 2006), rural-urban residence (Yoder et al., 2004), region 
(Johnson & Way, 2006, Yoder et al., 2004), religion (Okonofua et al., 2002, Yoder et al., 2004), 
ethnicity (Okonofua et al., 2002, Yoder et al., 2004), household wealth status (Johnson & Way, 
2006), education (Igwegbe & Egbuonu, 2000, Okonofua et al., 2002) and marital status (Johnson 
& Way, 2006, Okonofua et al., 2002). We used standard five-year age cohorts in this analysis: 
ages 15-19; 20-24; 25-29; 30-34; 35-39; 40-44; and 45-49. Household wealth was assessed using 
a wealth index constructed through a principal components analysis of items, assessing housing 
characteristics and amenities as well as household ownership of various assets. We also included 
the following reproductive, behavioural and health-related measures that may be associated with 
FGM/C and/or HIV: parity (Humphrey et al., 2007), number of lifetime sexual partners (Choudhry 
et al., 2015), recent sexual activity (sexual intercourse in the 12 months preceding the survey), 
experience of sexually transmitted infections (STIs) or STI symptoms such as abnormal vaginal 
discharge or a genital sore or ulcer (Okonofua et al., 2002) in the 12 months preceding the survey, 
and exposure to mass media (LaCroix et al., 2014).  
Statistical Analysis 
We computed descriptive statistics to explore variations in women’s HIV prevalence by FGM/C 
status and by key background characteristics. Due to sample size limitations (HIV prevalence was 
relatively low in three out of the four countries) we conducted a limited analysis to explore 
associations between FGM/C status and HIV prevalence in Ethiopia, The Gambia and Sierra 
Leone. For Kenya, which had data with relatively high HIV prevalence, we conducted a multivariate 
analysis. We calculated confidence intervals (CIs) around the HIV prevalence point estimates for 
women with and without FGM/C and noted statistically significant differences. Datasets were 
analysed separately for each country (and for each survey round for Kenya and Sierra Leone) and 
were not pooled. 
For the 2003 and 2008-2009 Kenya datasets (where a significant association was observed 
between FGM/C status and HIV prevalence), multilevel logistic modelling was applied to explore 
the determinants of HIV and their association with FGM/C. Models included the following variables: 
FGM/C status, residence, age group, education, wealth quintile, marital status, parity, recent 
sexual activity (past 12 months), number of lifetime sexual partners, STI or STI symptoms within 
the last 12 months and exposure to mass media.  
The DHS data have a hierarchical structure with individuals nested within clusters, which are 
nested within regions. In the multilevel analysis, regions constituted the highest (third) level, while 
clusters (primary sampling units) within regions constituted the second level. Each of the 
independent variables were included separately as a fixed effect to determine its association with 
HIV (univariate analysis, Model 1). In Model 2, we adjusted the association of HIV and FGM/C for 
these independent variables. In all analyses, including the bivariate analysis, we accounted for 
clustering and the hierarchical nature of the data by including random effects of clusters nested 
within regions nested within a country. In addition, we applied sample weights as provided in the 




HIV Prevalence and FGM/C Status 
As shown in Table 1, rates of FGM/C were high (>70%) in all countries except Kenya (28.7% in 
2008-9 and 33.1% in 2003). Types I and II FGM/C were predominant in all countries apart from 
Ethiopia, where Type III was common (data not shown). Overall, HIV prevalence ranged from 1.7% 
(Ethiopia) to 8.7% (Kenya 2003).  
Table 1. HIV prevalence by FGM/C status, according to country and survey year 
FGM/C Status 
HIV Status  
Total Number of women 
HIV-Negative HIV-Positive 
ETHIOPIA DHS 2005 
Uncut 97.9% 2.4% 100.0%  1,400  
Cut 
 
98.5% 1.5% 100.0%  4,541  
Don't Know 95.3% 4.7% 100.0% 169 
Total 98.3% 1.7% 100.0%  6,110  
Number of women  6,004   106   6,110   
THE GAMBIA DHS 2013 
Uncut 98.6% 1.5% 100.0%  1,066  
Cut 
 
97.6% 2.4% 100.0%  3,300  
Don't Know 100.0% 0.0% 100.0% 3 
Total 97.9% 2.1% 100.0%  4,369  
Number of women  4,276   93   4,369   
SIERRA LEONE DHS 2008 
Uncut 98.4% 1.9% 100.0% 249 
Cut 
 
98.3% 1.7% 100.0%  3,164  
Total 98.3% 1.7% 100.0%  3,413  
Number of women  3,355   58   3,413  
 
SIERRA LEONE DHS 2013 
Uncut 98.1% 1.9% 100.0% 794 
Cut 
 
98.4% 1.6% 100.0%  7,059  
Total 98.3% 1.7% 100.0% 7853 
Number of women  7,723   130   7,853  
 
KENYA DHS 2003 
Uncut 89.7% 10.3% 100.0%  2,235  
Cut 
 
94.2% 5.8% 100.0%  1,104  
Total 91.2% 8.7% 100.0%  3,339  
Number of women  3,045   291   3,339   
KENYA DHS 2008-09 
Uncut 90.7% 9.3% 100.0%  2,636  
Cut 
 
94.9% 5.1% 100.0%  1,063  
Total 92.0% 8.0% 100.0%  3,699  
Number of women  3,402   297   3,699  
 
 
In Kenya, HIV prevalence was significantly lower among cut women compared to uncut women in 
both surveys (Table 2). Figures 1 and 2 show the HIV prevalence by FGM/C status in the 2003 
and 2008-09 surveys, respectively. HIV prevalence was not associated with FGM/C status in the 







Table 2. HIV prevalence by FGM/C status, with confidence intervals and p-values according to 
country and survey year 




ETHIOPIA DHS 2005 
Uncut 2.4 (1.6, 3.6) 0.051  1,400  
Cut 
 
1.5           (1.1, 2.2)   4,541  
THE GAMBIA DHS 2013 
Uncut 1.5 (0.8, 2.6) 0.117  1,066  
Cut 
 
2.4           (1.8, 3.2)   3,300  
SIERRA LEONE DHS 2008 
Uncut 1.9 (0.8, 4.4)  0.846 249 
Cut 
 
1.7           (1.3, 2.3)   3,164  
SIERRA LEONE DHS 2013 
Uncut 1.9 (1.0, 3.7) 0.621 794 
Cut 
 
1.6           (1.3, 2.0)   7,059  
KENYA DHS 2003 
Uncut 10.3 (8.8, 12.0) <0.001  2,235  
Cut 
 
5.8 (4.4, 7.6)   1,104  
KENYA DHS 2008-09 
Uncut 
 
9.3 (7.7, 11.1) 0.008  1,063  






































Figure 2: HIV Prevalence By FGM/C Status, Kenya DHS  2008-09 
 
 
Analyses of Kenya DHS 2003 and 2008-2009  
The results of the additional analyses on the relationship between HIV prevalence and FGM/C 
status in the 2003 and 2008-09 Kenya DHS (KDHS) datasets are shown in Table 3 (descriptive 
analysis) and Table 4 (adjusted analysis).  
Table 3. Proportion of HIV positive women by FGM/C status, and various background and 
sexual behaviour-related characteristics, Kenya (2003 and 2008-09) 
  2008-09 KDHS 2003 KDHS 
Characteristic  % Number % Number 
FGM/C Status 
 Not cut 9.3 2,773 10.2 2,235 
 Cut 5.1 1,062 5.8 1,104 
Residence 
 Urban 10.6 880 12.3 725 
 Rural 7.4 2,955 7.7 2,613 
Age Group 
 15-19 2.9 791 3.0 767 
 20-24 6.5 768 9.5 687 
 25-29 10.6 678 12.8 548 
 30-34 11.1 531 11.5 459 
 35-39 9.0 383 11.7 365 
 40-44 14.3 362 9.8 294 
 45-49 6.6 323 4.0 218 
Education 
 No education 6.1 327 4.4 425 
 Primary 9.1 2,193 9.9 1,984 
 Secondary 6.7 1,034 8.0 753 
 Higher 8.2 281 8.7 177 
Wealth Quintile 
 Poorest 6.3 694 4.0 564 
























  2008-09 KDHS 2003 KDHS 
Characteristic  % Number % Number 
 Middle 6.8 668 7.2 657 
 Fourth 7.5 857 9.9 706 
 Richest 10.3 952 12.4 760 
Marital Status 
 Never married  3.7 1,190 4.8 959 
 Monogamous 6.0 1,938 7.2 1,629 
 Polygamous 12.3 280 11.8 357 
 Don’t know 7.9 32 7.3 40 
Parity 
 0 2.3 1,016 3.6 910 
 1  12.2 529 13.3 482 
 2-4 10.7 1,412 11.5 1,125 
 5+ 8.2 877 8.0 821 
Recent Sexual Activity 
 No 7.8 1,103 5.9 967 
 Yes 8.2 2,722 9.9 2,366 
Number of Lifetime Sexual Partners 
 0 7.4 3,337 7.5 2,925 
 1 13.2 472 16.0 376 
 Multiple 11.6 16 34.4 33 
 Missing 12.3 10 15.3 5 
Experience of STI/STI Symptoms 
 No 7.5 3,647 8.3 3,224 
 Yes 20.0 188 19.6 115 
Exposure to Mass Media (Radio) 
 None 6.9 526 7.4 508 
 
Less than once a 
week 9.3 350 8.4 280 
 At least once a week 8.2 2,959 9.0 2,551 
 
In general, women who were cut were less likely than those who were uncut to be HIV+ in both 
unadjusted (OR 0.65 [0.45, 0.94]) and adjusted (AOR 0.49 [0.31, 0.76]) models in the 2008-2009 
Kenya sample (Table 4). A similar pattern is observed using the 2003 sample of Kenyan women 
(OR 0.56 [0.40, 0.78] and AOR 0.60 [0.41, 0.89], respectively). 
Age  
In the sample, Kenyan women who were aged 20 years or older were generally more likely to be 
HIV+ than those ages 15 to 19 years in both Kenya survey rounds, in the unadjusted analysis. 
After adjustment, however, a mixed pattern is observed. In the 2008-2009 multivariate models, 
age cohort was no longer associated with HIV status, whereas in 2003, women in all age groups 
between 20 and 44 years were more likely to be HIV+ compared to those aged 15–19 years, with 
the highest odds among those aged 25–29 years (AOR 3.58 [1.73, 7.42]) and 30–34 years (AOR 
3.07 [1.36, 6.91]).  
Residence 
Rural Kenyan women in the sample were less likely than their urban counterparts to be HIV+ in 
the unadjusted (OR 0.54 [0.38, 0.78]) analyses in 2008-2009. However, the adjusted odds ratio is 
only marginally statistically significant (AOR 0.59 [0.35, 1.01]). Loss of statistical significance in the 




No clear pattern was observed by women’s education level in the 2008-2009 KDHS. In the 2003 
KDHS, women with primary education were more likely than those without any education to be 
HIV+ (AOR 2.55 [1.17, 5.56]). Those with secondary and higher education were just as likely as 
women without education to be HIV+.  
Household Wealth 
In the 2008-2009 adjusted model, women in the richest quintile were significantly more likely to be 
HIV+ than women in the poorest quintile (AOR 2.16 [1.05, 4.43]). In the 2003 KDHS, the odds of 
being HIV+ rose with increasing wealth in the unadjusted analysis. However, only women in the 
richest two quintiles were significantly more likely to have HIV (AOR 2.28 [1.14, 4.55] and AOR 
2.57 [1.18, 5.58], respectively) than women in the poorest quintile in the multivariate analysis.  
Marital Status 
In both surveys, women in monogamous and polygamous unions had higher odds of being HIV+ 
than never married women in the unadjusted models (2008-09: 1.85 [1.29, 2.67]; OR 2.79 [1.71, 
4.54], respectively) and (2003: OR 1.84 [1.26, 2.67]; OR 2.99 [1.81, 4.93], respectively). Marital 
status was not associated with HIV status in the multivariate models in either survey.   
Parity 
In general, women with one or more children were more likely to be HIV+ in the unadjusted analysis 
for both surveys, compared to those with no children. After adjustment, in the 2008-2009 survey, 
this finding still holds, except for the odds ratio related to having five or more children, which was 
only marginally statistically significant (AOR 2.25 [0.99, 5.10]). In 2003, only women with one child 
were more likely than those with no children to be HIV+.  
Lifetime Number of Sexual Partners 
In 2008-2009 survey, only women with one partner were more likely to be HIV+ than the reference 
group. After adjustment, models including the categories “multiple partners” and “missing” did not 
converge in both survey rounds due to small cell sizes, so no inferences can be made about 
whether the associations observed hold in multivariate models. In the unadjusted models based 
on the 2003 KDHS, women with one (OR 2.04 [1.45, 2.85]) or multiple (OR 4.11 [1.69, 10.04]) 
partners were more likely to be HIV+ than women who reported no sexual partners.  
Recent Sexual Activity 
Recent sexual activity was not associated with HIV status in the 2008-09 sample. In 2003, women 
reporting recent sexual activity had a higher likelihood of being HIV+ in the unadjusted models. 
However, this association was non-significant in the adjusted model.  
Sexually Transmitted Infection within the Past 12 months 
Women who reported STI or STI symptoms in the 12 months preceding the survey were more 
likely to be HIV+ than those who report otherwise, in both unadjusted and adjusted analysis, in 
both surveys (AOR 2.09 [1.20, 3.66] in 2008-09; AOR 1.91 [1.01, 3.62] in 2003).   
Exposure to Mass Media 
There was no relationship between women’s exposure to mass media (radio) and HIV status in 




Table 4: Unadjusted and adjusted odds ratios for the association between FGM/C and HIV, Kenya (2003 and 2008-09) 
  2008-09 KDHS  2003 KDHS 
  Unadjusted  Adjusted  Unadjusted  Adjusted 
Characteristic  OR (95% CI) P value  AOR (95% CI) P value  OR (95% CI) P value  AOR (95% CI) P value 
FGM/C Status 
 Not cut ref   ref   ref   ref  
 Cut 0.65(0.45-0.94) 0.022  0.49(0.31-0.76) 0.002  0.56(0.40-0.78) 0.001  0.60(0.41-0.89) 0.01 
Residence             
 Urban ref   ref   ref   ref  
 Rural 0.54(0.38-0.78) 0.001  0.59(0.35-1.01) 0.055  0.48(0.34-0.68) <0.001  0.65(0.40-1.08) 0.097 
Age Group 
 15-19 ref   ref   ref   ref  
 20-24 1.97(1.20-3.23) 0.007  0.89(0.49-1.62) 0.693  2.75(1.67-4.51) <0.001  1.98(1.09-3.58) 0.024 
 25-29 3.70(2.27-6.02) <0.001  1.47(0.76-2.82) 0.254  4.40(2.68-7.24) <0.001  3.53(1.84-6.77) 0 
 30-34 5.06(3.08-8.31) <0.001  1.43(0.69-2.94) 0.336  4.17(2.51-6.94) <0.001  3.58(1.73-7.42) 0.001 
 35-39 4.15(2.45-7.01) <0.001  1.42(0.65-3.11) 0.384  4.08(2.39-6.99) <0.001  3.07(1.36-6.91) 0.007 
 40-44 4.30(2.48-7.44) <0.001  1.52(0.66-3.48) 0.326  3.14(1.74-5.67) <0.001  3.11(1.26-7.69) 0.014 
 45-49 2.88(1.60-5.17) <0.001  0.92(0.36-2.32) 0.861  1.47(0.66-3.26) 0.348  1.16(0.30-4.54) 0.833 
Education 
 No education ref   ref   ref   ref  
 Primary 0.90(0.55-1.46) 0.659  0.83(0.43-1.58) 0.569  1.99(1.17-3.40) 0.012  2.55(1.17-5.56) 0.019 
 Secondary 0.67(0.39-1.15) 0.144  0.50(0.24-1.04) 0.063  1.54(0.86-2.76) 0.15  1.32(0.56-3.09) 0.523 
 Higher 0.59(0.30-1.16) 0.129  0.51(0.22-1.22) 0.129  1.36(0.64-2.88) 0.429  0.89(0.32-2.46) 0.824 
Wealth Quintile 
 Poorest ref   ref   ref   ref  
 Second 1.36(0.87-2.12) 0.172  1.63(0.93-2.88) 0.089  1.90(1.07-3.39) 0.029  1.83(0.94-3.58) 0.077 
 Middle 1.18(0.74-1.88) 0.488  1.44(0.79-2.63) 0.232  2.06(1.15-3.69) 0.015  1.57(0.78-3.16) 0.211 
 Fourth 1.23(0.78-1.96) 0.369  1.44(0.77-2.69) 0.249  3.10(1.78-5.40) <0.001  2.28(1.14-4.55) 0.019 
 Richest 1.68(1.06-2.67) 0.027  2.16(1.05-4.43) 0.036  3.55(2.03-6.20) <0.001  2.57(1.18-5.58) 0.017 
Marital Status 
 Never married  ref   ref   ref   ref  
 Monogamous 1.85(1.29-2.67) 0.001  0.86(0.35-2.11) 0.738  1.84(1.26-2.67) 0.001  1.21(0.48-3.08) 0.69 
 Polygamous 2.79(1.71-4.54) <0.001  1.36(0.54-3.42) 0.513  2.99(1.81-4.93) <0.001  1.97(0.76-5.08) 0.16 
 Don't know 2.42(0.67-8.73) 0.176  0.99(0.22-4.34) 0.986  1.74(0.49-6.13) 0.389  1.12(0.25-4.92) 0.882 
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  2008-09 KDHS  2003 KDHS 
  Unadjusted  Adjusted  Unadjusted  Adjusted 
Characteristic  OR (95% CI) P value  AOR (95% CI) P value  OR (95% CI) P value  AOR (95% CI) P value 
Parity 
 0 ref   ref   ref   ref  
 1 3.51(2.17-5.69) <0.001  3.14(1.72-5.72) <0.001  4.32(2.74-6.83) <0.001  2.20(1.23-3.94) 0.008 
 2-4 4.88(3.21-7.42) <0.001  3.43(1.74-6.75) <0.001  3.82(2.52-5.77) <0.001  1.28(0.65-2.50) 0.471 
 >5 3.65(2.32-5.76) <0.001  2.25(0.99-5.10) 0.052  2.31(1.45-3.68) <0.001  0.62(0.27-1.44) 0.266 
Recent Sexual Activity 
 No ref   ref   ref   ref  
 Yes 1.19(0.90-1.58) 0.23  1.04(0.46-2.32) 0.929  1.68(1.22-2.30) 0.001  1.24(0.52-2.94) 0.634 
Number of Lifetime Sexual Partners 
 0 ref   ref   ref   ref  
 1 1.88(1.37-2.59) <0.001  1.36(0.58-3.20) 0.48  2.04(1.45-2.85) <0.001  1.59(0.67-3.74) 0.292 
 Multiple 1.23(0.26-5.78) 0.791     4.11(1.69-10.04) 0.002  0.79(0.09-7.04) 0.835 
 Missing 1.73(0.20-15.09) 0.62     5.85(0.53-65.08) 0.151    
Experience of STI/STI Symptoms 
 No ref   ref   ref   ref  
 Yes 3.24(2.15-4.89) <0.001  2.09(1.20-3.66) 0.01  2.54(1.50-4.30) 0.001  1.91(1.01-3.62) 0.046 
Exposure to Mass Media (Radio) 
 None ref   ref   ref   ref  
 Less than once a week 1.39(0.83-2.33) 0.215  1.07(0.54-2.11) 0.85  1.20(0.68-2.12) 0.534  1.09(0.52-2.26) 0.826 





This study represents a limited analysis of six nationally-representative population-based surveys to 
explore the association between HIV prevalence and FGM/C status among women aged 15 to 49 
years in four countries (Ethiopia, The Gambia, Kenya and Sierra Leone). We found no difference in 
HIV prevalence between women who have undergone FGM/C and uncut women in Ethiopia, The 
Gambia and Sierra Leone. In contrast, we found a negative association between FGM/C status and 
HIV prevalence in both the Kenyan surveys. The negative association remained significant when we 
controlled for demographic and behavioural variables that in other studies have been associated with 
HIV prevalence such as marital status, whether a woman was sexually active, parity, lifetime number 
of sexual partners and experiencing an STI.  
The negative association between FGM/C and HIV found in the Kenya samples conflicts with the 
theory that FGM/C increases risk of HIV for cut women. The reasons for this finding are not 
immediately clear. However, previous studies using Kenya DHS data have proposed that cut women 
may limit engagement in sexual intercourse and may be less likely to engage in pre-marital and extra-
marital sex (e.g. Yount and Abraham, 2007). In addition, the regional variation in FGM/C and HIV 
status in Kenya — the north eastern region ranking highest in FGM/C prevalence while simultaneously 
having one of the lowest HIV prevalence — makes it difficult to ascertain an association between HIV 
and FGM/C. Previous studies using Kenya DHS data (Maslovskaya et al., 2009, Yount and Abraham, 
2007) found that FGM/C and HIV may be indirectly associated through various pathways.  
Study findings should be interpreted in light of several limitations. Firstly, HIV prevalence is relatively 
low in three of the four countries (Ethiopia, The Gambia, Sierra Leone). Thus, the number of HIV+ 
women when assessed by FGM/C status (and, further, by background sub-groups) is very small (<25) 
in three of the four countries. The small numbers of HIV+ women make it difficult to reach meaningful 
conclusions on the association between HIV prevalence and FGM/C status, whether nationally, or by 
background or behavioural characteristics. The Kenya 2003 and 2008-2009 surveys are the only ones 
with large enough numbers of HIV+ women to reach somewhat reliable conclusions, although as 
stated earlier, the marked regional variation in HIV and FGM/C prevalence may mask any 
associations. Future research should use data from moderate HIV prevalence countries to yield more 
robust analyses.  
Secondly, the DHS datasets used self-reported FGM/C status, which is known to be less reliable than 
clinical exam (Elmusharaf, Elhadi & Almroth, 2006). While recognising that it is not feasible to conduct 
clinical exams during DHS implementation, studies using other types of samples or data sources may 
benefit from augmentation with clinical records, where available.   
Lastly, only women who affirmatively responded that they had been cut were classified as having 
FGM/C. It is possible, however, that some of those who responded “don’t know” may have been cut. 
Future analyses should compare the characteristics of women who answered “don’t know” to those 
who answered “yes” and to those who answered “no”, to explore the possibility of recoding FGM/C 
status, for sensitivity analyses. 
Conclusions 
Findings were inconsistent across the country samples studied. This study found no statistically 
significant difference in HIV prevalence between women with FGM/C and those without in Ethiopia, 
The Gambia and Sierra Leone. In contrast, cut women in Kenya were less likely to be HIV positive 
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than uncut women. The reason for the lack of consistency of findings is unclear but may be related to 
study limitations, such as the possibility of indirect pathways of association that were not considered 
in the analyses and the considerable geographical variation in HIV prevalence that makes it difficult to 
assess its association with FGM/C, particularly in low HIV-prevalence settings.  
Considering that FGM/C causes trauma to the genitalia which can increase susceptibility to sexually 
transmitted infections further research is warranted. Such research would benefit from the use of 
samples with adequate numbers of HIV+ women for more robust analysis while exploiting more 
sophisticated statistical techniques. Additionally, self-reported FGM/C status data should be supported 
or verified with clinical records where possible and, where not possible, the recoding of the responses 
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